Docteur XAVIER MARIETTE
✨ Profil synthétique
IA · 04/05/2026Le Docteur Xavier Mariette est un rhumatologue hospitalier à Le Kremlin-Bicêtre, avec une production scientifique importante (h-index de 111 et 1026 publications). Ses recherches portent principalement sur les maladies auto-immunes, notamment la polyarthrite rhumatoïde, le lupus érythémateux systémique et la spondylarthrite. Il a également dirigé plusieurs thèses dans le domaine de l'immunologie.
Expertises présumées
- Rheumatoid Arthritis
- Sjögren
- Lupus érythémateux systémique
- Spondylarthrite
- Thérapies biothérapeutiques non-anti-TNF
- Inhibiteurs de JAK
- csDMARDs
- Épidémiologie des maladies rhumatismales
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- Rhumatologie (SM)
🎯 Capacités
- Cancérologie (C)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Direction de thèses
🎓 6 thèses dirigéesDéveloppement d'organoïdes de glande salivaire dans la maladie de Sjögren : un outil innovant pour l'étude de la maladie et l'identification de nouvelles thérapies ciblées
2024Doctorant·e : Loïc Meudec
Immunologie🎓 université Paris-SaclayRôle des cellules épithéliales salivaires au cours du Syndrome de Sjögren primitif
2020Doctorant·e : Élodie Rivière
Immunologie🎓 université Paris-SaclayMise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation
2018Doctorant·e : Samuel Bitoun
Immunologie🎓 Université Paris-Saclay (ComUE)Mécanismes de la lymphomagenèse au cours des maladies auto-immunes : rôle de la génétique, de l'activité de la maladie et des traitements
2015Doctorant·e : Gaetane Nocturne
Immunologie🎓 Université Paris-Saclay (ComUE)Causes et conséquences de l’activation de l’interféron de type I dans les maladies auto-immunes. Étude dans le modèle du syndrome de Sjögren
2012Doctorant·e : Nicolas Gestermann
Immunologie🎓 Paris 11Lien entre l'immunité innée, la cytokine BAFF (B-cell activating factor of TNF family) et l'auto-immunité
2009Doctorant·e : Marc Ittah
Immunologie🎓 Paris 11
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
111
h articles cités ≥ h fois chacun. Un h de 111 = 111 publications avec 111+ citations.
Citations
52 922
Publications
1026
i10-index
440
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×320
- Salivary Gland Disorders and Functions ×286
- Systemic Lupus Erythematosus Research ×212
- Lymphoma Diagnosis and Treatment ×94
- Spondyloarthritis Studies and Treatments ×93
Affiliations FR : Inserm · Université Paris-Saclay · Assistance Publique – Hôpitaux de Paris
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study
2026ArticleSeminars in Arthritis and Rheumatism
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
2026ArticleJCI Insight
A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
2026ArticleAnnals of the Rheumatic Diseases
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study
2025ArticleThe Lancet Rheumatology
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren’s disease
2025ArticleAnnals of the Rheumatic Diseases
Unraveling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
2025CongrèsACR Convergence 2025
Clinical presentation, course, treatment and outcome of juvenile onset versus adult onset mixed connective tissue disease patients: a multicenter retrospective cohort
2025CongrèsACR Convergence 2025
Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
2025ArticleRMD Open
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
GHU APHP UPS SITE KREMLIN BICETRE APHP
78 Avenue DU GENERAL LECLERC, 94275 Le Kremlin-Bicêtre
☎ 0145212121Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Articles de presse (4)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- « L’hôpital public n’est plus capable d’amortir la moindre crise sanitaire, même si elle est prévisible » - Le Monde.fr
📰 Le Monde.fr · 21/12/2022
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxQRHBGZFVIRzZCN29rMks5ZVJjVzFDdC15bWtLZkhDX21GQ0xSZUw2Q3RlRGVqZEc4c0JPMTVVNGltaGxDMWhob1NPeEdUV0hQaktjb3RHUVRMVjc2NGlTUktxbWIxZFhUcGJQV3BGVWlWUGJQZkJuYkNfbkpCZnZPZ1BtbEVmQXhiNVhDeTR3cEk5MUIzckJvRndHNTZQR0R2d1h2a0VCZXlac3NHUUZrSzNEMmEtMlI0N0
- À la fac de médecine du Kremlin-Bicêtre : un bâtiment d'excellence pour poursuivre la recherche malgré la crise - Citoyens.com
📰 Citoyens.com · 09/12/2022
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOVlNZbGp0T2ZZemdKYUVneEVySmxncmxGdGd6alRHZ3U4RDhUelVQNkV4UHR2SnhqOC1xWEE0U2QwMk1lbGxBT1NJX0wxVDdXb19TSnFpVGZCcXc4TnhvSUlfTFlfUUhZemJwWC1Cb0NuaV9SZTA5TTdzUUwxWThIdVlmckcwc1lkWHduSGhaRGM0NC0yWkxXTHRWMFRGcXZrUWN1M29oOEZyNzh3b3k5Yld6YzcwSUF3X2
- Maladie de Sjögren : y penser face à la triade sécheresse, fatigue, douleurs - vidal.fr
📰 vidal.fr · 24/05/2022
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQU0xONThCR3NxM01QUzBpa1lrWW00QWNnNUVOeWRTTUFzZHhDbHN3ZWZBekwyOERmVDhvdVZ1cUlJa1BWd1dJd1hUZEV1ZmdoVWRHRzZMbXdhTEdBUzQ0Y3BKUU0xMXh1U3RxU25RUGdZU1lNLW40MWh5cEdiYjMzTlpTSEkyMlVCTjN3Rng5YnhIYnZhRmtQWTZwd2RkVmVfSld4WVVlMU5qa0xuRzVzMjMzb1Q2UQ?oc=
- L’appel de 1 376 médecins de l’AP-HP : « La culture du chiffre, du “bla-bla” et des “process” sape le moral des personnels hospitaliers » - Le Monde.fr
📰 Le Monde.fr · 09/12/2021
<a href="https://news.google.com/rss/articles/CBMimAJBVV95cUxNLS1DSWZLenRhaFVxbVdOMWpMc3o2elB6dXIzVExZNjVoQ1dsZ00wZGJjSEwzYVJrX3pKZlI2NmhTU0Raa19mWG9pSENsWnc0bFZkc1hkZEZxazNKMmU5dVV0UjFJSmdhdEFXVEFINGJhSDdkdWtyWU5nQ3pUTlJfX3pIQXk4aDFRZm1Rd1BRbXJ5MXpYTm5QWm0tVVRPUWFtajg3SUJ4Z1cwVXNKbjIwYnhJNFcwUWpxQ1
Top publications · les plus citées
- 12023 International Rome consensus for the nomenclature of Sjögren disease
Nature reviews. Rheumatology · 2025
- 2CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
The Lancet. Rheumatology · 2025
📚 28 citations🎯 RCR 10.18 - 3Precision medicine in Sjögren's disease
The Lancet. Rheumatology · 2024
📚 18 citations🎯 RCR 4.10Top 10% NIH
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Sjögren21
▼
Sjögren21
▼- The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms
NPJ systems biology and applications · 2026 · Journal Article
E Silva-Saffar S, Mariette X, Gottenberg JE, Bombardieri M, et al.
- Update on the Aetiopathogenesis of Sjögren Disease: From Interferon Signaling to Epithelial Dysfunction
Journal of clinical medicine · 2026 · Journal Article
Meudec L, Nocturne G, Mariette X
- Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjögren's disease
Current opinion in immunology · 2026 · Journal Article
Yang T, Goudarzi N, Kroese FGM, Mariette X, et al.
- A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
Annals of the rheumatic diseases · 2026 · Journal Article
Beydon M, Dulin M, Ly B, Verstuyft C, et al.
- Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
Annals of the rheumatic diseases · 2025 · Journal Article
Chevet B, Devauchelle-Pensec V, Pontarini E, Baloche V, et al.
- Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study
The Lancet. Rheumatology · 2025 · Journal Article
Duquesne J, Basseto L, Claye C, Barnes M, et al.
📚 4 cit. - Association between anti-SSA/SSB antibody profiles and patient-reported outcomes in primary Sjögren's disease
Rheumatology (Oxford, England) · 2025 · Journal Article
Robert M, Nguyen Y, Belkhir R, Desmoulins F, et al.
- A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials
The Journal of rheumatology · 2025 · Journal Article
Beydon M, Nguyen Y, Gordon R, Foulquier N, et al.
📚 5 cit.🎯 RCR 2.10 - Cutaneous Vasculitis in Primary Sjögren Disease
JAMA dermatology · 2025 · Journal Article
Breillat P, Le Guern V, d'Humières T, Battistella M, et al.
📚 1 cit. - Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
Annals of the rheumatic diseases · 2025 · Journal Article
Bowman SJ, Seror R, Porcher R, Arends S, et al.
📚 10 cit.🎯 RCR 4.23 - 2023 International Rome consensus for the nomenclature of Sjögren disease
Nature reviews. Rheumatology · 2025 · Consensus Statement
Ramos-Casals M, Baer AN, Brito-Zerón MDP, Hammitt KM, et al.
📚 45 cit.🎯 RCR 18.89🔬→🩺 Translationnel - Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease
Annals of the rheumatic diseases · 2025 · Journal Article
Meudec L, Goudarzi N, Silva-Saffar SE, Pascaud J, et al.
📚 5 cit.🎯 RCR 1.98 - Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Nguyen Y, Beydon M, Gottenberg JE, Morel J, et al.
📚 12 cit.🎯 RCR 4.86 - Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Dörner T, Bowman SJ, Fox R, Mariette X, et al.
📚 12 cit.🎯 RCR 4.82🩺 Clinique - Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis
Rheumatology (Oxford, England) · 2025 · Journal Article
Astouati Q, Machet T, Houssais C, Noury JB, et al.
📚 6 cit.🎯 RCR 2.59 - Impact of Sjögren's disease on quality of sexual life using the Qualisex score
RMD open · 2025 · Journal Article
Kachaner A, Seror R, Le Guern V, Dieudé P, et al.
- Stability of symptom-based subtypes in Sjogren's disease
RMD open · 2024 · Journal Article
Berry JS, Tarn J, Casement J, Lendrem D, et al.
📚 3 cit. - Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease
RMD open · 2024 · Journal Article
Georgel L, Benyoussef AA, Berrouiguet S, Guellec D, et al.
📚 2 cit.🩺 Clinique - Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study
The Lancet. Rheumatology · 2024 · Journal Article
Rocca J, Beydon M, Le Guern V, Hachulla E, et al.
📚 10 cit.🎯 RCR 2.20🩺 Clinique - m(6)A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease
Annals of the rheumatic diseases · 2024 · Journal Article
Truffinet F, Arco-Hierves A, Shalabi H, Pascaud J, et al.
📚 16 cit.🎯 RCR 2.87 - Precision medicine in Sjögren's disease
The Lancet. Rheumatology · 2024 · Journal Article
Gandolfo S, Bombardieri M, Pers JO, Mariette X, et al.
📚 18 cit.🎯 RCR 4.10🔬→🩺 Translationnel
Transversal17
▼
Transversal17
▼- Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort
RMD open · 2026 · Journal Article
Dusser P, Nguyen Y, Perrin C, Frénoy P, et al.
- Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans
bioRxiv : the preprint server for biology · 2026 · Journal Article
Calderón DO, Kilpatrick LE, Conil C, Philippot Q, et al.
- Immune checkpoint inhibitor-induced joint involvement
Presse medicale (Paris, France : 1983) · 2026 · Journal Article
Quelain J, Henry J, Belkhir R, Mariette X, et al.
- Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
JCI insight · 2026 · Journal Article
Lenoir O, Morin F, Walter-Petrich A, Resmini L, et al.
🩺 Clinique - Macrophage Cell Culture and Characterization by Serum Human AB in Health and Disease
Methods in molecular biology (Clifton, N.J.) · 2026 · Journal Article
Paoletti A, Ly B, Bitoun S, Nocturne G, et al.
- Lessons from organoid engineering for rheumatic disease
Joint bone spine · 2026 · Journal Article
Meudec L, Goudarzi N, Mariette X, Nocturne G
- Sicca induced by immune checkpoint inhibitors
Presse medicale (Paris, France : 1983) · 2025 · Journal Article
Belkhir R, Gosset M, Rousseau A, Bitoun S, et al.
- Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland
Annals of the rheumatic diseases · 2025 · Journal Article
Wiley MM, Radziszewski M, Khatri B, Joachims ML, et al.
📚 4 cit. - Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
Annals of the rheumatic diseases · 2025 · Journal Article
Boucly A, Mitrovic S, Carmagnat M, Savale L, et al.
📚 9 cit.🎯 RCR 3.69 - Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis
Rheumatology (Oxford, England) · 2025 · Journal Article
Ahmed S, Pfeiffer RM, Jackson SS, Song M, et al.
📚 3 cit. - Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies
RMD open · 2025 · Journal Article
Robert M, Nguyen Y, Allenbach Y, Sacre K, et al.
- CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
The Lancet. Rheumatology · 2025 · Journal Article
Scherlinger M, Nocturne G, Radic M, Launay D, et al.
📚 28 cit.🎯 RCR 10.18🔬→🩺 Translationnel - Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course
Rheumatology (Oxford, England) · 2025 · Journal Article
Chanson N, Galvagni A, Ramos-Casals M, Ruiz JI, et al.
📚 8 cit.🎯 RCR 3.31 - Iscalimab 600 mg: justified or excessive? - Authors' reply
Lancet (London, England) · 2025 · Letter
Fisher BA, Mariette X, Hueber W
- Transient migratory osteoporosis of epiphyseal lower limbs during FLOT chemotherapy for gastric cancer
Joint bone spine · 2025 · Letter
Bouchut A, Grimon G, Mariette X, Nocturne G
- Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value
RMD open · 2025 · Journal Article
Cioni P, Chretien P, Goulvestre C, Ballot E, et al.
📚 6 cit.🎯 RCR 2.81 - Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines
Clinical and experimental immunology · 2025 · Journal Article
Naigeon M, Bitoun S, Roulleaux Dugage M, de Oliveira C, et al.
Biothérapies non-anti-TNF3
▼
Biothérapies non-anti-TNF3
▼- Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
Annals of the rheumatic diseases · 2025 · Journal Article
Chevet B, Devauchelle-Pensec V, Pontarini E, Baloche V, et al.
- Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
Joint bone spine · 2025 · Journal Article
Morel J, Wetzman A, Wendling D, Soubrier M, et al.
📚 1 cit. - Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
BMJ open · 2025 · Clinical Trial Protocol
Pascart T, Fautrel B, Gottenberg JE, Ducoulombier V, et al.
🩺 Clinique
Connectivite mixte3
▼
Connectivite mixte3
▼- Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study
Seminars in arthritis and rheumatism · 2026 · Journal Article
Chevalier K, Bader-Meunier B, Kone-Paut I, Thoreau B, et al.
- Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
RMD open · 2025 · Journal Article
Chevalier K, Thoreau B, Michel M, Godeau B, et al.
🩺 Clinique - Treatment of mixed connective tissue disease: A multicenter retrospective study
Journal of autoimmunity · 2025 · Journal Article
Chevalier K, Thoreau B, Michel M, Godeau B, et al.
📚 5 cit.🎯 RCR 2.18🩺 Clinique
JAK inhibiteurs3
▼
JAK inhibiteurs3
▼- JAK inhibitor withdrawal causes a transient pro-inflammatory cascade: A potential mechanism for major adverse cardiac events
PloS one · 2025 · Journal Article
Gurevic I, Meudec L, Mariette X, Nocturne G, et al.
📚 1 cit. - JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Cascade: A Potential Mechanism for Major Adverse Cardiac Events
bioRxiv : the preprint server for biology · 2025 · Journal Article
Gurevic I, Meudec L, Mariette X, Nocturne G, et al.
- Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes
RMD open · 2025 · Journal Article
Mariette X, Borchmann S, Aspeslagh S, Szekanecz Z, et al.
📚 6 cit.🎯 RCR 2.58🩺 Clinique
csDMARDs2
▼
csDMARDs2
▼- Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
Annals of the rheumatic diseases · 2025 · Journal Article
Chevet B, Devauchelle-Pensec V, Pontarini E, Baloche V, et al.
- Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
The Lancet. Rheumatology · 2025 · Journal Article
Morel J, Dernis E, Roux C, Richez C, et al.
📚 2 cit.🩺 Clinique
Épidémiologie & registres2
▼
Épidémiologie & registres2
▼- Early-life animal and farming exposures and the risk of rheumatoid arthritis: findings from the E3N French cohort study
RMD open · 2025 · Journal Article
Dusser P, Nguyen Y, Perrin C, Frénoy P, et al.
🩺 Clinique - Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry
Annals of the rheumatic diseases · 2024 · Journal Article
Farisogullari B, Lawson-Tovey S, Hyrich KL, Gossec L, et al.
📚 3 cit.
Anti-TNF1
▼
Anti-TNF1
▼- Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology (Oxford, England) · 2025 · Journal Article
Nguyen Y, Baron G, Hamamouche N, Belkhir R, et al.
📚 1 cit.🩺 Clinique
IA en rhumatologie1
▼
IA en rhumatologie1
▼- Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study
The Lancet. Rheumatology · 2025 · Journal Article
Duquesne J, Basseto L, Claye C, Barnes M, et al.
📚 4 cit.
Datasets & protocoles partagés
Immunocytochemical analysis of BAFF expression in salivary epithelilal cells from minor salivary glands
Image2011figshare<b>Copyright information:</b>Taken from "B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome"A
Induction of BAFF mRNA by epithelial cells from minor salivary glands
Image2011figshare<b>Copyright information:</b>Taken from "B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome"A
Effect of tumour necrosis factor (TNF) antagonists on anti-mycobacterial proliferative response
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
Expression of membrane-bound tumour necrosis factor (mTNF) after 4 hours of incubation with infliximab (Ifx)
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach
Collection2020figshareAbstract Background With the growth in use of biotherapic drugs in various medical fields, the occurrence of anti-drug antibodies represents nowadays a serious issue. This immune response against a drug can be due either
CD4<sup>+</sup> T-cell DNA methylation changes during pregnancy significantly correlate with disease-associated methylation changes in autoimmune diseases
Dataset2022Taylor & FrancisEpigenetics may play a central, yet unexplored, role in the profound changes that the maternal immune system undergoes during pregnancy and could be involved in the pregnancy-induced modulation of several autoimmune dise
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).